News

Element Solutions Inc's Upcoming Earnings: What to Expect

Element Solutions Inc's Upcoming Earnings: What to Expect

Element Solutions Inc's Upcoming Earnings

Element Solutions Inc (NYSE: ESI) is gearing up to announce its quarterly earnings report soon, a highly anticipated event for shareholders and investors alike. As the reporting date approaches, the excitement among market players continues to build. This report serves as a guide for those keeping an eye on Element Solutions.

Analyst Expectations for Earnings

Analysts project that Element Solutions will report an earnings per share (EPS) of $0.36. This prediction reflects optimism about the company’s growth trajectory and overall financial health.

Significance of Earnings Guidance

The earnings announcement is not just about the figures but also the guidance provided by the company. For new investors, the guidance can serve as a critical factor influencing stock price movements. Positive guidance often results in favorable reactions in the market.

Historic Earnings Performance

In the previous quarter, Element Solutions exceeded EPS expectations by $0.01, leading to a notable 6.82% increase in share price the day following the announcement. A history of beating estimates can instill confidence in current and prospective investors.

Current Stock Performance Overview

As of now, shares of Element Solutions are priced at approximately $23.17. Over the past year, the stock has seen a decline of about 6.77%. This downturn might lead long-term shareholders to approach the upcoming earnings release with a certain level of caution.

Analyst Insights and Expectations

The market sentiment surrounding Element Solutions plays a crucial role in shaping investor expectations. Analysts currently have a consensus rating of 'Outperform,' indicating confidence in the company's future performance. The average one-year price target is set at $28.0, suggesting a potential upside of 20.85%, which further highlights the optimistic forecasts held by market analysts.

Comparing Performance to Industry Peers

To better understand Element Solutions's position within the sector, it's essential to compare its future outlook with that of its peers, such as Celanese, Balchem, and Axalta Coating Systems. These comparisons help shed light on how Element Solutions stands relative to its competitors.

  • Celanese is currently expected to have a neutral trajectory, with an average one-year price target of $64.6, indicating a potential upside of 178.81%.
  • Balchem’s projections show a more aggressive buy recommendation with an estimated price target of $189.0, predicting a staggering 715.71% upside.
  • As for Axalta Coating Systems, the analysts favor an 'Outperform' rating, with a price target of $36.71, showing a potential upside of 58.44%.

Insights from Peer Analysis

An analysis of key performance indicators among Element Solutions and its peers reveals essential takeaways. Element Solutions leads with revenue growth at 2.04%, while its gross profit of $266.40M places it at a disadvantage compared to some of its counterparts.

Understanding Element Solutions

Element Solutions Inc specializes in providing advanced chemical solutions, playing a critical role in enhancing everyday products through its unique offerings. The company operates primarily in two segments: Electronics and Industrial & Specialty. The Electronics segment, being the most significant revenue generator, focuses on developing specialty chemicals and technologies for electronic hardware manufacturing.

Key Financial Highlights of Element Solutions

Market Capitalization: The company's market cap has faced limitations relative to industry benchmarks, suggesting impactful operational dynamics.

Revenue Growth: The company has recently reported a revenue growth rate of 2.04%, demonstrating an upward trend in earnings, outpacing many competitors in the sector.

Net Margin: Element Solutions showcases a robust net margin of 7.58%, signifying its adeptness in cost management and profitability.

Return on Equity (ROE): Standing at 1.84%, the ROE illustrates the effective use of equity to generate profits.

Return on Assets (ROA): With a ROA of 0.97%, the company displays efficiency in making the most of its assets.

Debt Management: A healthy debt-to-equity ratio of 0.62 positions the company favorably among its peers, reflecting sound financial practices.

Frequently Asked Questions

What is the expected EPS for Element Solutions's upcoming earnings report?

Analysts anticipate an EPS of $0.36 for the upcoming report.

How has Element Solutions performed in the past few quarters?

The company has shown resilience, with a notable EPS beat in the last quarter resulting in a 6.82% increase in share price.

What is the current stock price for Element Solutions?

Element Solutions shares are currently trading at about $23.17.

How does Element Solutions's revenue growth compare to its peers?

Element Solutions leads with 2.04% revenue growth among its compared peers.

What guidance should investors expect from Element Solutions?

Investors are looking for positive guidance that could influence stock price movements following the earnings release.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LONGi's Four Paths to Global Green Development

Updated Category News Views 62

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 149

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 469

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 92

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading

Top 5 Most Recently Viewed Articles

AAVantgarde's Professor Auricchio Receives Prestigious Role

Updated Category News Views 177

AAVantgarde's Professor Auricchio Achieves New Milestone MILAN, a milestone moment has arrived for AAVantgarde Bio as Professor Alberto Auricchio, the visionary Founder and Chief Scientific Officer, has been elected President of the European Society of Gene and Cell Therapy. This prestigious appointment recognizes his exceptional contributions and unwavering commitment to...

Continue Reading
How Bitcoin's Drop Affects Strategy Inc (NASDAQ: MSTR) Investors

Updated Category News Views 137

Understanding the Current Market Landscape As recent market trends demonstrate, Strategy Inc (NASDAQ: MSTR) is seeing significant activity. On one hand, the company is evidently reliant on the performance of Bitcoin. With such dependence, the fluctuations in the value of Bitcoin are crucial to the health of MSTR. This situation poses both risks and opportunities for...

Continue Reading
Significant Attorney Departures to Strengthen Association Law Firm

Updated Category News Views 99

Major Attorney Moves to Association Law Group (ALG) In a noteworthy shift within Florida's community association law landscape, several prominent attorneys have transitioned from Becker & Poliakoff to join the ranks of Association Law Group (ALG). Among them, Michael C. Gongora, Lilliana Farinas-Sabogal, and Adam Cervera are recognized for their extensive experience in...

Continue Reading
EQB's Commitment to Sustainability in Financial Services

Updated Category News Views 175

EQB Focuses on Sustainability in Its Latest Report EQB Inc. (TSX: EQB) has recently published a detailed Responsibility Report, highlighting significant strides towards its sustainability commitments. This annual report encapsulates the company's dedication to fostering an environment of innovation within the Canadian banking sector, with a particular focus on enriching...

Continue Reading
BofA's Downgrade of Sandvik: Navigating Market Pressures Ahead

Updated Category News Views 103

BofA Securities dropped a bomb on Sandvik AB back then by downgrading it from Neutral to Underperform. This move sent shockwaves through the trading floor, mainly because they saw some serious trouble brewing in Sandvik’s Machining and Manufacturing Solutions (SMMS) division. Traders were quick to pick up on the whispers about short cycle pressures that could really...

Continue Reading